Topological role of cytochrome P450 2D6 active site residues

被引:9
|
作者
van Waterschoot, RAB
Keizers, PHJ
de Graaf, C
Vermeulen, NPE
Tschirret-Guth, RA [1 ]
机构
[1] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
[2] Vrije Univ Amsterdam, LACDR, Div Mol Toxicol, Dept Pharmacochem, NL-1081 HV Amsterdam, Netherlands
关键词
cytochrome p450 2D6; active site topology; aryldiazenes; mutagenesis; molecular modeling;
D O I
10.1016/j.abb.2006.01.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent reports have identified Phe120, Asp301, Thr309, and Glu216 as important residues in cytochrome P450 2D6 (CYP2D6) substrate binding and catalysis. Complementary homology models have located these amino acids within the binding pocket of CYP2D6 and in the present study we have used aryldiazenes to test these models and gain further insight in the role these amino acids have in maintaining the integrity of the active site cavity. When Phe120 was replaced to alanine, there was a significant increase in probe migration to pyrrole nitrogens C and D, in agreement with homology models which have located the phenyl side-chain of Phe120 above these two pyrrole rings. No changes in topology were observed with the D301Q mutant, supporting claims that in this mutant the electrostatic interactions with the B/C-loop are largely maintained and the loop retains its native orientation. The T309V Mutation resulted in significant topological alteration suggesting that, in addition to its potential role in dioxygen activation, Thr309 plays an important structural role within the active site crevice. Replacement of Ile106 with Glu, engineered to cause electrostatic repulsion with Glu216, had a profound topological effect in the higher region within the active site cavity and impaired the catalytic activity towards CYP2D6 probe substrates. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 50 条
  • [21] Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity
    Bogdanos, DP
    McFarlane, IG
    JOURNAL OF HEPATOLOGY, 2003, 39 (05) : 860 - 863
  • [22] The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent
    Lussenburg, BMA
    Keizers, PHJ
    de Graaf, C
    Hidestrand, M
    Ingelman-Sundberg, M
    Vermeulen, NPE
    Commandeur, JNM
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (08) : 1253 - 1261
  • [23] The role of phenylalanine 483 in Cytochrome P450 2D6 is strongly substrate dependent
    Lussenburg, BMA
    Keizers, PHJ
    De Graaf, C
    Vermeulen, NPE
    Commandeur, JNM
    DRUG METABOLISM REVIEWS, 2005, 37 : 31 - 31
  • [24] Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6
    Keizers, PHJ
    Schraven, LHM
    de Graaf, C
    Hidestrand, M
    Ingelman-Sundberg, M
    van Dijk, BR
    Vermeulen, NPE
    Commandeur, JNM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (02) : 1065 - 1074
  • [25] Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism
    Unwalla, Rayomand J.
    Cross, Jason B.
    Salaniwal, Sumeet
    Shilling, Adam D.
    Leung, Louis
    Kao, John
    Humblet, Christine
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2010, 24 (03) : 237 - 256
  • [26] Analysis of cytochrome P450 2D6:substrate interactions by site-directed mutagenesis
    Hanna, IH
    Gillam, EMJ
    Guengerich, FP
    FASEB JOURNAL, 1998, 12 (08): : A1427 - A1427
  • [27] Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6
    Ellis, SW
    Hayhurst, GP
    Lightfoot, T
    Smith, G
    Harlow, J
    Rowland-Yeo, K
    Larsson, C
    Mahling, J
    Lim, CK
    Wolf, CR
    Blackburn, MG
    Lennard, MS
    Tucker, GT
    BIOCHEMICAL JOURNAL, 2000, 345 : 565 - 571
  • [28] Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism
    Rayomand J. Unwalla
    Jason B. Cross
    Sumeet Salaniwal
    Adam D. Shilling
    Louis Leung
    John Kao
    Christine Humblet
    Journal of Computer-Aided Molecular Design, 2010, 24 : 237 - 256
  • [29] Evidence that aspartic acid 301 and glutamic acid 216 are not alternative ligand-binding residues in the active site of cytochrome P450 2D6
    Ellis, SW
    Keenan, L
    Harlow, J
    Chowdry, J
    Gregory, A
    Modi, S
    Eddershaw, PJ
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 444P - 445P
  • [30] Cytochrome P450 2D6 inhibitory constituents of Lunasia amara
    Takahashi, Subehan Naoto
    Kadota, Shigetoshi
    Tezuka, Yasuhiro
    PHYTOCHEMISTRY LETTERS, 2011, 4 (01) : 30 - 33